Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/influence-of-the-c161t-but-not-pro12ala-polymorphism-in-the-peroxisome-9KkGaJl2R0
References (49)
-
J. Auwerx, G. Martin, M. Guerre-Millo, B. Staels (1996)
Transcription, adipocyte differentiation, and obesityJournal of Molecular Medicine, 74
-
Yang-Yi Fan, T. Spencer, Naisyin Wang, M. Moyer, R. Chapkin (2003)
Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes.Carcinogenesis, 24 9
-
P. Stattin, A. Lukanova, C. Biessy, S. Söderberg, R. Palmqvist, R. Kaaks, T. Olsson, E. Jellum (2004)
Obesity and colon cancer: Does leptin provide a link?International Journal of Cancer, 109
-
Wendy Smith, Xiao-ping Zhou, K. Kurose, Xin Gao, F. Latif, T. Kroll, K. Sugano, S. Cannistra, S. Clinton, E. Maher, T. Prior, C. Eng (2001)
Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma casesHuman Genetics, 109
-
K. Wada, A. Nakajima, R. Blumberg (2001)
PPARgamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease.Trends in molecular medicine, 7 8
-
S. Deeb, L. Fajas, M. Nemoto, J. Pihlajamäki, L. Mykkänen, J. Kuusisto, M. Laakso, W. Fujimoto, J. Auwerx (1998)
A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivityNature Genetics, 20
-
J. Hardwick, G. Brink, G. Offerhaus, S. Deventer, M. Peppelenbosch (2001)
Leptin is a growth factor for colonic epithelial cells.Gastroenterology, 121 1
-
J. Auwerx (2002)
Nuclear receptors. I. PPAR gamma in the gastrointestinal tract: gain or pain?American journal of physiology. Gastrointestinal and liver physiology, 282 4
-
S. Tomita, H. Kawamata, J. Imura, F. Omotehara, Y. Ueda, T. Fujimori (2002)
Frequent polymorphism of peroxisome proliferator activated receptor gamma gene in colorectal cancer containing wild-type K-ras gene.International journal of molecular medicine, 9 5
-
X. Wang, J. Oosterhof, N. Duarte (1999)
Peroxisome proliferator-activated receptor gamma C161-->T polymorphism and coronary artery disease.Cardiovascular research, 44 3
-
Xing-li Wang, J. Oosterhof, N. Duarte (1999)
Peroxisome proliferator-activated receptor γ C161→T polymorphism and coronary artery diseaseCardiovascular Research, 44
-
C. Siezen, Astrid Leeuwen, Nicolien Kram, M. Luken, H. Kranen, E. Kampman (2004)
Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption.Carcinogenesis, 26 2
-
Takayuki Ikezoe, Carl Miller, Seiji Kawano, Anthony Heaney, Elizabeth Williamson, Junichi Hisatake, Eric Green, Wolf Hofmann, Hirokuni Taguchi, H. Koeffle (2001)
Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies.Cancer research, 61 13
-
S. Loffreda, S. Yang, H. Lin, C. Karp, ML Brengman, D. Wang, A. Klein, G. Bulkley, C. Bao, P. Noble, M. Lane, A. Diehl (1998)
Leptin regulates proinflammatory immune responses.FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 12 1
-
P. Sarraf, E. Mueller, Wendy Smith, H. Wright, J. Kum, L. Aaltonen, A. Chapelle, B. Spiegelman, C. Eng (1999)
Loss-of-Function Mutations in PPARγ Associated with Human Colon CancerMolecular Cell, 3
-
P. Stattin, R. Palmqvist, S. Söderberg, C. Biessy, B. Ardnor, G. Hallmans, R. Kaaks, T. Olsson (2003)
Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden.Oncology reports, 10 6
-
P. Sarraf, E. Mueller, Daniel Jones, F. King, D. DeAngelo, Jeffrey Partridge, S. Holden, L. Chen, S. Singer, C. Fletcher, B. Spiegelman (1998)
Differentiation and reversal of malignant changes in colon cancer through PPARγNature Medicine, 4
-
J. Auwerx (2002)
I. PPARγ in the gastrointestinal tract: gain or pain?American Journal of Physiology-gastrointestinal and Liver Physiology, 282
-
A. Doney, B. Fischer, D. Frew, Alastair Cumming, D. Flavell, M. World, H. Montgomery, D. Boyle, A. Morris, C. Palmer (2002)
Haplotype analysis of the PPARγ Pro12Ala and C1431T variants reveals opposing associations with body weightBMC Genetics, 3
-
L. Fajas, D. Auboeuf, E. Raspé, K. Schoonjans, A. Lefebvre, R. Saladin, J. Najib, M. Laville, J. Fruchart, S. Deeb, A. Vidal-Puig, J. Flier, M. Briggs, B. Staels, H. Vidal, J. Auwerx (1997)
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene*The Journal of Biological Chemistry, 272
-
L. Fajas, J. Fruchart, J. Auwerx (1998)
PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoterFEBS Letters, 438
-
E. Tai, D. Corella, M. Deurenberg-Yap, Xian Adiconis, Suok Chew, C. Tan, J. Ordovás (2004)
Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population.Journal of lipid research, 45 4
-
Adrian Mander (2001)
Haplotype Analysis in Population-based Association StudiesThe Stata Journal, 1
-
J. Brockman, Rajnish Gupta, R. Dubois (1998)
Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cellsGastroenterology, 115
-
J. Brockman, R. Gupta, R. Dubois (1998)
Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells.Gastroenterology, 115 5
-
R. Dubois, Rajnish Gupta, J. Brockman, Bandaru Reddy, S. Krakow, M. Lazar (1998)
The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers.Carcinogenesis, 19 1
-
Jurg Ott (2000)
Predicting the range of linkage disequilibrium.Proceedings of the National Academy of Sciences of the United States of America, 97 1
-
J. Cheng, K. Ogawa, K. Kuriki, Y. Yokoyama, T. Kamiya, K. Seno, H. Okuyama, Jingweng Wang, Chenhong Luo, Toshiko Fujii, H. Ichikawa, T. Shirai, S. Tokudome (2003)
Increased intake of n-3 polyunsaturated fatty acids elevates the level of apoptosis in the normal sigmoid colon of patients polypectomized for adenomas/tumors.Cancer letters, 193 1
-
C. Yen, B. Beamer, C. Negri, K. Silver, K. Brown, D. Yarnall, D. Burns, J. Roth, A. Shuldiner (1997)
Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor γ (hPPARγ) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPARγ2 Missense MutationBiochemical and Biophysical Research Communications, 241
-
D. Campa, S. Zienolddiny, V. Maggini, V. Skaug, A. Haugen, F. Canzian (2003)
Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer.Carcinogenesis, 25 2
-
E. Saez, P. Tontonoz, M. Nelson, J. Alvarez, U. Ming, S. Baird, V. Thomazy, R. Evans (1998)
Activators of the nuclear receptor PPARgamma enhance colon polyp formation.Nature medicine, 4 9
-
R. Paynter, S. Hankinson, G. Colditz, D. Hunter, I. Vivo (2004)
No evidence of a role for PPARgamma Pro12Ala polymorphism in endometrial cancer susceptibility.Pharmacogenetics, 14 12
-
C. Yen, B. Beamer, C. Negri, K. Silver, K. Brown, D. Yarnall, D. Burns, J. Roth, A. Shuldiner (1997)
Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation.Biochemical and biophysical research communications, 241 2
-
Yang-Yi Fan, T. Spencer, Naisyin Wang, M. Moyer, R. Chapkin (2003)
Chemopreventive n-3 fatty acids activate RXRα in colonocytesCarcinogenesis, 24
-
Xiao-ping Zhou, Wendy Smith, O. Gimm, E. Mueller, Xin Gao, P. Sarraf, T. Prior, C. Plass, A. Deimling, P. Black, A. Yates, C. Eng (2000)
Over-representation of PPARγ sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general populationJournal of Medical Genetics, 37
-
S. Landi, V. Moreno, Lydie Gioia-Patricola, E. Guinó, M. Navarro, J. Oca, G. Capellá, F. Canzian (2003)
Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer.Cancer research, 63 13
-
A. Memisoglu, S. Hankinson, J. Manson, G. Colditz, D. Hunter (2002)
Lack of association of the codon 12 polymorphism of the peroxisome proliferator-activated receptor gamma gene with breast cancer and body mass.Pharmacogenetics, 12 8
-
G. Girnun, Wendy Smith, S. Drori, P. Sarraf, E. Mueller, C. Eng, P. Nambiar, D. Rosenberg, R. Bronson, W. Edelmann, R. Kucherlapati, F. Gonzalez, B. Spiegelman (2002)
APC-dependent suppression of colon carcinogenesis by PPARγProceedings of the National Academy of Sciences of the United States of America, 99
-
Rajendra Mehta, Elizabeth Williamson, Minu Patel, H. Koeffler (2000)
A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.Journal of the National Cancer Institute, 92 5
-
D. Fallin, N. Schork, N. Schork (2000)
Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data.American journal of human genetics, 67 4
-
A. Meirhaeghe, Lluis ajas, N. Helbecque, D. Cottel, P. Lebel, J. Dallongeville, S. Deeb, J. Auwerx, P. Amouyel (1998)
A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans.Human molecular genetics, 7 3
-
T. Kubota, K. Koshizuka, E. Williamson, H. Asou, Jonathan Said, S. Holden, I. Miyoshi, H. Koeffler (1998)
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.Cancer research, 58 15
-
L. Fajas, J. Fruchart, J. Auwerx (1998)
PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter.FEBS letters, 438 1-2
-
K. Wada, A. Nakajima, R. Blumberg (2001)
PPARγ and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's diseaseTrends in Molecular Medicine, 7
-
D. Paltoo, K. Woodson, PhilipR. Taylor, D. Albanes, J. Virtamo, J. Tangrea (2003)
Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study.Cancer letters, 191 1
-
J. Sánchez, M. Ríos, C. Pérez, M. Laakso, M. Larrad (2002)
Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.European journal of endocrinology, 147 4
-
Zhihong Gong, D. Xie, Z. Deng, R. Bostick, S. Muga, T. Hurley, J. Hébert (2004)
The PPARγ Pro12Ala polymorphism and risk for incident sporadic colorectal adenomasCarcinogenesis, 26
-
Chun-Xia Yang, T. Takezaki, K. Hirose, M. Inoue, Xin-en Huang, K. Tajima (2003)
Fish consumption and colorectal cancer: a case–reference study in JapanEuropean Journal of Cancer Prevention, 12
-
N. Niho, Mami Takahashi, Y. Shoji, Y. Takeuchi, S. Matsubara, T. Sugimura, K. Wakabayashi (2003)
Dose‐dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPARγ ligandCancer Science, 94
- Publisher
- Wiley
- Copyright
- Copyright © 2005 Wiley Subscription Services, Inc., A Wiley Company
- eISSN
- 1349-7006
- DOI
- 10.1111/j.1349-7006.2005.00072.x
- pmid
- 16108832
- Publisher site
- See Article on Publisher Site
Abstract
Journal
Cancer Science – Wiley
Published: Aug 1, 2005